Anti-Cancer CAS 122111-03-9 Gemcitabine HCLAPI Gemcitabine HydrochlorideRaw MaterialGemcitabine
Product Description
Product Details
Product name
Gemcitabine Hydrochloride
Appearance
White powder
CAS NO.
122111-03-9
MF
C9H12ClF2N3O4
MW
263.198146
Gemcitabine hydrochloride is a synthetic novel difluoro nucleoside drug that is anti-metabolic and antineoplastic. It is researched and developed by the Eli Lilly and Company and approved to be listed in South Africa, Sweden, the Netherlands, Australia and other countries in 1995. The United States Food and Drug Administration ( referred FDA) approved it as the first-line therapy for the clinical treatment of non-small cell lung cancer and pancreatic cancer.
Application&Function
Gemcitabine hydrochloride is a 2'-deoxycytidine hydrochloriode having geminal fluoro substituents in the 2'-position. An inhibitor of ribonucleotide reductase, gemcitabine hydrochloride is used in the treatment of various carcinomas, including non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer.